The Brighterside of News on MSN
Breakthrough new drug lowers blood sugar and burns fat without muscle loss
A new study offers fresh hope for people living with type 2 diabetes and obesity. Researchers report progress toward a pill ...
New studies show that pharmacological treatment with GLP-1-RA and dual GLP-1/glucose-dependent insulinotropic polypeptide receptor agonists (GIP-RA) cause almost as much weight loss as gastric surgery ...
MedPage Today on MSN
Surgery beats GLP-1 drugs for fat loss, muscle retention, study suggests
Bariatric surgery and GLP-1 receptor agonists both reduced fat mass over 2 years of treatment, but surgery was associated ...
As the new year begins, many are using glucagon-like peptide-1 receptor agonists (GLP-1RAs) for weight loss. While effective, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. NATIONAL HARBOR, Md. — GLP-1 receptor agonists are ...
Filed two patent applications for lead candidate EL-22, covering muscle loss in obese patients as a monotherapy and in combination with GLP-1 receptor agonists Elevai Biosciences patent portfolio now ...
Rapid weight loss can cause a greater loss of muscle mass than losing weight slowly. The popularity of newer weight-loss drugs that shed pounds quickly has raised concerns among researchers about how ...
Filed two patent applications for lead candidate EL-22, covering muscle loss in obese patients as a monotherapy and in combination with GLP-1 receptor agonists Elevai Biosciences patent portfolio now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback